We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.

Nature | Oct 7, 2010

Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (Pol II). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 Å resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxy-terminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel α-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 Å from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.

Pubmed ID: 20861839 RIS Download

Mesh terms: Animals | Binding Sites | Carrier Proteins | Catalytic Domain | Crystallography, X-Ray | Drosophila Proteins | Humans | Models, Molecular | Nuclear Proteins | Phosphopeptides | Phosphoprotein Phosphatases | Polyadenylation | Protein Binding | Protein Structure, Secondary | Protein Structure, Tertiary | RNA Polymerase II | Saccharomyces cerevisiae Proteins | Substrate Specificity | mRNA Cleavage and Polyadenylation Factors

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NIGMS NIH HHS, Id: R01 GM028983
  • Agency: NIGMS NIH HHS, Id: GM077175
  • Agency: NIGMS NIH HHS, Id: R01 GM077175
  • Agency: NIGMS NIH HHS, Id: R01 GM028983-31
  • Agency: NIBIB NIH HHS, Id: P30 EB009998
  • Agency: NIGMS NIH HHS, Id: R01 GM077175-04
  • Agency: NIGMS NIH HHS, Id: GM028983

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.